Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 147158, 8 pages
http://dx.doi.org/10.1100/2012/147158
Research Article

Characterization of the Immune Response Induced by a Commercially Available Inactivated Bluetongue Virus Serotype 1 Vaccine in Sheep

1VISAVET Health Surveillance Centre and Animal Health Department, Veterinary Faculty, Complutense University of Madrid, Avenida Puerta de Hierro s/n, 28040 Madrid, Spain
2Department of Comparative Pathology, Veterinary Faculty, University of Córdoba, Animal Health Building, Rabanales Campus, 14014 Córdoba, Spain

Received 18 October 2011; Accepted 22 December 2011

Academic Editors: E. Carrillo and K. E. Kester

Copyright © 2012 Ana Cristina Pérez de Diego et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Jenna Anderson, Sara Hägglund, Emmanuel Bréard, Loic Comtet, Karin Lövgren Bengtsson, John Pringle, Stéphan Zientara, and Jean Francois Valarchera, “Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle,” Clinical and Vaccine Immunology, vol. 20, no. 8, pp. 1115–1122, 2013. View at Publisher · View at Google Scholar
  • Coraline Bouet-Cararo, Vanessa Contreras, Agathe Caruso, Sokunthea Top, Marion Szelechowski, Corinne Bergeron, Cyril Viarouge, Alexandra Desprat, Anthony Relmy, Jean-Michel Guibert, Eric Dubois, Richard Thiery, Emmanuel Breard, Stephane Bertagnoli, Jennifer Richardson, Gilles Foucras, Gilles Meyer, Isabelle Schwartz-Cornil, Stephan Zientara, and Bernard Klonjkowski, “Expression of VP7, a Bluetongue Virus Group Specific Antigen by Viral Vectors: Analysis of the Induced Immune Responses and Evaluation of Protective Potential in Sheep,” Plos One, vol. 9, no. 11, 2014. View at Publisher · View at Google Scholar
  • Helene Guis, David Pleydell, Emilie Gay, Didier Calavas, Benoit Durand, Christian Ducrot, and Renaud Lancelot, “Did Vaccination Slow the Spread of Bluetongue in France?,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar
  • D. Scott McVey, and N. James MacLachlan, “Vaccines for Prevention of Bluetongue and Epizootic Hemorrhagic Disease in Livestock: A North American Perspective,” Vector-Borne and Zoonotic Diseases, vol. 15, no. 6, pp. 385–396, 2015. View at Publisher · View at Google Scholar
  • A.C. Pérez de Diego, J.C. Gómez-Villamandos, J.M. Sánchez-Vizcaíno, F.J. Pleguezuelos, B. Garfia, P. del Carmen, M. Pedrera, and P.J. Sánchez-Cordón, “Comparative analysis of cellular immune responses and cytokine levels in sheep experimentally infected with bluetongue virus serotype 1 and 8,” Veterinary Microbiology, 2015. View at Publisher · View at Google Scholar
  • Christie Mayo, Justin Lee, Jennifer Kopanke, and N. James MacLachlan, “A review of potential bluetongue virus vaccine strategies,” Veterinary Microbiology, 2017. View at Publisher · View at Google Scholar